Gene therapy aims to treat or prevent diseases by modifying or correcting defective genes within a patient’s cells. Using techniques such as viral vectors, CRISPR gene editing, and RNA-based delivery systems, gene therapy can restore normal cellular function, replace missing proteins, or silence harmful mutations. This innovative field has shown significant promise in inherited disorders, including muscular dystrophy, hemophilia, immune deficiencies, and certain forms of blindness. In oncology, gene therapy approaches modify immune cells to recognize and destroy cancer cells, revolutionizing cancer treatment. As technologies advance, gene therapy is moving toward safer, more targeted, and long-lasting treatments.
| Stage 1 |
Initial Quality & Plagiarism Check The manuscript is reviewed for journal scope, basic submission requirements, ethical compliance, and similarity/plagiarism concerns. |
| Stage 2 |
Editorial Assessment & Peer Review Manuscripts that pass the initial screening undergo editorial assessment and independent peer review in accordance with the journal's peer-review policy. |
| Stage 3 |
Revision & Editorial Decision Authors may be requested to revise their manuscript based on reviewer and editor comments. A final editorial decision is made after the required review and revision stages are completed. |
| Stage 4 |
Production & Publication Accepted manuscripts proceed to production, author proofing, final quality checks, and online publication. |
| English | Publication Language |
| Single-Blind | Peer-Review Model |
| 17% | Acceptance Rate |
| <18% | Similarity Screening Guideline |
| Open Access | Access Model |
All manuscripts undergo editorial assessment and originality screening as part of the journal's evaluation process. The acceptance rate shown is based on journal-level editorial data and may change over time. Similarity reports are assessed editorially and are not interpreted solely on the basis of a numerical similarity score.